• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Prothena

positive negative up down good bad mixed
Biotech

Novo Nordisk shares mixed data behind pivotal heart disease push

Neither coramitug cohort performed better than the placebo arm on the six-minute walk test, causing the trial to miss one of its primary endpoints.
Nick Paul Taylor Nov 11, 2025 8:32am
human brain abstract art

Prothena Alzheimer's trial hit by ARIA showstopper

Aug 28, 2025 6:48am
A series of dice with a bag on them illustrating cost cuts

Prothena lays off 63% in fallout from phase 3 amyloidosis fail

Jun 20, 2025 2:23am
balloon missed target pop arrows miss failure

Prothena reburies drug after 2nd swing at rare disease misses

May 27, 2025 3:33am
long shot miss basketball hoop fail shoot

Roche's Prothena-partnered Parkinson's prospect fails phase 2b

Dec 19, 2024 4:31am
cellos without players

UCB-Novartis Parkinson's asset fails to improve symptoms in ph. 2

Dec 16, 2024 3:19pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings